Diarrheal diseases have long been a significant global health challenge, particularly affecting vulnerable populations such as children under 5 and the elderly. However, a comprehensive study by the Institute for Health Metrics and Evaluation (IHME) published in The Lancet Infectious Diseases
The biotech industry is on the brink of a significant transformation, driven by advancements in genetic validation, data-centric investment strategies, and the integration of real-world data (RWD) in clinical trials. By 2025, these innovations are expected to revolutionize cardiovascular research
The digital health industry has witnessed remarkable advancements in 2024, driven by the integration of artificial intelligence (AI) and the growing emphasis on personalized care. High-level executives from various sectors of the healthcare industry have shared their insights on these
The intricate relationship between our gut microbiota and the risk of developing colon cancer has captivated scientific interest recently, revealing new layers of complexity in how our body's internal systems interact. Researchers at the University of Wisconsin-Madison have discovered that
Washington University School of Medicine in St. Louis (WashU Medicine) has been awarded a significant five-year, $10.8 million grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH). This funding renewal aims to advance the institution's ongoing research in
In a significant breakthrough, Poolbeg Pharma announced positive pre-clinical study results for their drug POLB 001, presented at the 66th American Society of Hematology (ASH) Annual Meeting. The study focused on the drug's potential to prevent Cytokine Release Syndrome (CRS), a frequently observed
A drug initially celebrated for its potential in treating a rare liver disease has come under scrutiny following alarming safety findings. Ocaliva, developed by Intercept Pharmaceuticals and now under Alfasigma's ownership, was initially viewed as a breakthrough treatment for primary biliary
Advancements in cancer therapy have brought significant hope, especially with immune checkpoint blockades (ICBs), providing a groundbreaking treatment strategy for advanced cancers. Despite this, the effectiveness of ICBs has often been thwarted by therapeutic resistance, which renders
Autoimmune encephalitis (AE), a condition where the body's immune system turns against the brain, affects approximately one-third of global encephalitis cases and often leads to debilitating symptoms, including seizures, cognitive impairment, and motor dysfunctions. Despite advancements in
Ovarian cancer represents a significant health concern worldwide, being the eighth most frequently diagnosed cancer and the leading cause of cancer-related mortality among women globally. In 2022 alone, the disease accounted for over 324,000 new cases and 206,839 deaths across the globe. This
